KIF20A Drives Anti-PD-1 Resistance in NSCLC
In the ever-evolving landscape of cancer immunotherapy, one of the most formidable challenges remains the innate resistance some tumors exhibit ...
Tag: immune checkpoint inhibitors in lung cancer
Immune Checkpoint Inhibition Shifts Failure Patterns in Lung Cancer
In a groundbreaking study published in the Journal of Cancer Research and Clinical Oncology, researchers led by J. Taugner and ...
Ablation Boosts Immunotherapy in Lung Cancer
In a groundbreaking advancement poised to reshape the therapeutic landscape for metastatic non-small cell lung cancer (NSCLC), researchers have launched ...
Advances in NSCLC Treatment Post-Chemoimmunotherapy
In recent years, the treatment paradigm for non-small-cell lung cancer (NSCLC) has undergone a transformative shift, primarily driven by the ...
Early Radiotherapy Boosts Survival in Extensive-Stage SCLC
In a groundbreaking advancement for the treatment of extensive-stage small cell lung cancer (ES-SCLC), recent research reveals that the timing ...
Some patients maintain long-term disease control despite stopping immune checkpoint inhibitors due to side effects
In a groundbreaking study that addresses one of the most challenging dilemmas in modern oncology, researchers have shed light on ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!